Clinical Trials Logo

Clinical Trial Summary

The overall hypothesis of this research study is that gluten intake alters intestinal barrier function in patients with Irritable Bowel Syndrome (IBS) diarrhea who also exhibit non-celiac gluten sensitivity (NCGS).


Clinical Trial Description

The specific aim of this hypothesis-generating, pilot study is to randomize (like the flip of a coin) patients who have Non Celiac Gluten Sensitivity to a 4-week Gluten-containing diet (GCD) or to a Gluten free diet (GFD). The study will evaluate small bowel (SB) permeability functionally (2-sugar differential excretion), morphologically, using probe-based confocal laser to evaluate the small intestinal, as well as molecularly, using tight junction (TJ) messenger RNA (mRNA) expression in small bowel mucosa in response to the different diets. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02098057
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date April 2014
Completion date September 19, 2016

See also
  Status Clinical Trial Phase
Completed NCT01675414 - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD) N/A
Completed NCT03383029 - iEAT 2.0 Open Trial N/A
Completed NCT02359396 - A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics Phase 1
Completed NCT05127408 - Gastrointestinal Tract Disorders: A Prospective Multicenter Registry
Completed NCT01695850 - A Double-blinded,Double-dummy Clinical Trial of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation Phase 2
Completed NCT01705626 - Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)